The biotech scorecard for the first quarter: 26 stock-moving events to watch https://t.co/s8upBQvSfF An alphabet's list of clinical trial readouts and FDA decisions on my curated list, from $ARWR to $XENE

The biotech scorecard for the first quarter: 26 stock-moving events to watch https://t.co/s8upBQvSfF An alphabet's list of clinical trial readouts and FDA decisions on my curated list, from $ARWR to $XENE
@Sanctuary_Bio $ARWR still wins though https://t.co/r2fbtClgqv